Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Disease × Mass Screening × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 3 Breast Neoplasms 2 Uterine Cervical Diseases 1 Squamous Intraepithelial Lesions 1 Postural Orthostatic Tachycardia Syndrome 1 Papillomavirus Infections 1 Pancreatic carcinoma, familial 1 Pancreatic cancer, adult 1 Mastocytosis 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 HIV Infections 1 Disease 1 Colorectal Neoplasms 1 Cervical Cancer Screening 1 Bronchopulmonary Disease 1

Interventions

Magnetic Resonance Imaging 2 Blood Specimen Collection 2 tislelizumab 1 pembrolizumab 1 fluorocholine 1 atezolizumab 1 Videotape Recording 1 TIC10 compound 1 Surveys and Questionnaires 1 Specimen Handling 1 Referral and Consultation 1 Prostatectomy 1 Preoperative Exercise 1 Positron Emission Tomography Computed Tomography 1 Pluvicto 1 Observation 1 Nephroureterectomy 1 Mass Screening 1 Mammography 1 Interleukin-15 1 Endosonography 1 Diagnostic Techniques and Procedures 1 Diagnostic Imaging 1 Cryosurgery 1 Control Groups 1 Clinical Laboratory Techniques 1 Biopsy, Fine-Needle 1 Biopsy 1 Bevacizumab 1 Antigens, Neoplasm 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04590560 2024-12-09

MISS

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase NA Recruiting

60,000 enrolled

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡